16 results on '"Xandri, M"'
Search Results
2. Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with < 10% Vs. >= 10% JAK2 V617F Allele Burden
3. MUTATIONAL STUDY IN 12 PATIENTS WITH MELOFIBROSIS TREATED USING RUXOLITINIB
4. CYTOGENETIC ALTERATIONS IN THE MOMENT OF RELAPSE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (LAM) WITH NORMAL KARYOTYPE, INTERNAL DUPLICATION IN TANDEM OF THE GENE FLT3 (DT-FLT3) AND NPM1WT IN DIAGNOSIS
5. MYELODYSPLASTIC SYNDROMES: USEFULNESS OF GENE EXPRESSION PROFILING FOR PROGNOSIS AND CELL MORPHOLOGY CLASSIFICATION
6. Clonal cytogenetic abnormalities in Ph-cells in a patien with chronic myelogenous leukemia (CML) treated with Imatinib
7. ANALYSIS OF FLT3-ITD IN 147 PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
8. FREQUENCY OF MUTATIONS IN THE GENE FOR HEAT IN PATIENTS WITH POLYCYTHEMIA VERA JAK2V617F NEGATIVE
9. Chronic myeloid leukaemia with masked chromosome Philadelphia: Usefulness of M-FISH study
10. Frequency and type of clonal chromosomal abnormalities following stem cell transplantation (SCT)
11. Association of JAK2 mutation status and cytogenetic abnormalities at diagnosis in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.
12. Diagnostic and prognostic contribution of targeted NGS in patients with triple-negative myeloproliferative neoplasms.
13. Clinical usefulness of fluorescence in situ hybridization for detection of MLL rearrangements in acute myeloid leukemia.
14. Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis.
15. [Evaluation of splenic function by dynamic gammagraphy, study of pitted erythrocytes and submembranous vacuoles in patients with slight and severe splenic trauma receiving conservative treatment or splenectomy].
16. Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.